EL Stock Analysis: Estee Lauder Companies | NYSE

Household & Personal Products | NYSE, USA | Market Cap: 33.803m USD | 12M Return: 14.1% | US5184391044 | Charts, Fundamentals & Technical Analysis

Skin Care, Makeup, Fragrance, Hair Care
Total Rating 53
Safety 85
Buy Signal 0.12
Household & Personal Products
Industry Rotation: +5.5
Market Cap: 33.8B
Avg Turnover: 294M
Risk 3d forecast
Volatility46.5%
VaR 5th Pctl7.21%
VaR vs Median-5.08%
Reward TTM
Sharpe Ratio0.43
Rel. Str. IBD66.1
Rel. Str. Peer Group65.8
Character TTM
Beta1.272
Beta Downside1.321
Hurst Exponent0.512
Drawdowns 3y
Max DD67.59%
CAGR/Max DD-0.17
CAGR/Mean DD-0.33
EPS (Earnings per Share) EPS (Earnings per Share) of EL over the last years for every Quarter: "2021-09": 1.89, "2021-12": 3.01, "2022-03": 1.9, "2022-06": 0.42, "2022-09": 1.37, "2022-12": 1.54, "2023-03": 0.47, "2023-06": 0.07, "2023-09": 0.11, "2023-12": 0.88, "2024-03": 0.97, "2024-06": 0.64, "2024-09": 0.14, "2024-12": 0.62, "2025-03": 0.65, "2025-06": 0.09, "2025-09": 0.32, "2025-12": 0.89, "2026-03": 0.91, "2026-06": 0.39,
EPS CAGR: 0.72%
EPS Trend: 3.3%
Last SUE: 0.48
Qual. Beats: 0
Revenue Revenue of EL over the last years for every Quarter: 2021-09: 4392, 2021-12: 5539, 2022-03: 4245, 2022-06: 3561, 2022-09: 3930, 2022-12: 4620, 2023-03: 3751, 2023-06: 3609, 2023-09: 3518, 2023-12: 4279, 2024-03: 3940, 2024-06: 3871, 2024-09: 3361, 2024-12: 4004, 2025-03: 3550, 2025-06: 3407, 2025-09: 3481, 2025-12: 4238, 2026-03: 3712, 2026-06: 3618,
Rev. CAGR: -2.03%
Rev. Trend: -66.1%
Last SUE: 0.04
Qual. Beats: 0

Warnings

P/E Ratio 186.9
Below Avwap Earnings

Tailwinds

Confidence

Seasonality 11.7 years of data

Jan +2.8% 8
Feb -0.1% 10
Mar +1.3% 5
Apr +0.0% 5
May -2.9% 18
Jun -0.4% 15
Jul +1.0% 29
Aug -0.5% 10
Sep -3.2% 43
Oct -2.6% 26
Nov +3.0% 25
Dec +6.5% 36

How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.

Description: EL Estee Lauder Companies

Estée Lauder Companies Inc. (NYSE: EL) is a global prestige beauty manufacturer and marketer of skin care, makeup, fragrance, and hair care products, founded in 1946 and headquartered in New York City. Its portfolio spans roughly 25 owned brands, including La Mer, Jo Malone London, TOM FORD, Clinique, M·A·C, The Ordinary, Estée Lauder, Aveda, and Bobbi Brown, reflecting a multi-brand house model typical of the personal care products sub-industry within Consumer Staples.

The company sells through a diversified channel mix that includes department stores, duty-free and travel retail, specialty multi-brand retailers, pharmacies, salons and spas, freestanding stores, and brand-direct e-commerce sites, along with third-party online platforms. This combination of brand prestige, global distribution, and exposure to travel retail is a defining feature of the prestige beauty business model and a key driver of the companys international revenue mix.

Headlines to Watch Out For
  • China travel retail weakness pressures quarterly revenue growth
  • Fragrance brands drive premium segment outperformance
  • Tariff and FX headwinds weigh on margins
Piotroski VR-10 (Strict) 5.5
Net Income: 182.0m TTM > 0 and > 6% of Revenue
FCF/TA: 0.07 > 0.02 and ΔFCF/TA 3.29 > 1.0
NWC/Revenue: 9.18% < 20% (prev 11.41%; Δ -2.23% < -1%)
CFO/TA 0.09 > 3% & CFO 1.77b > Net Income 182.0m
Net Debt (7.69b) to EBITDA (1.65b): 4.67 < 3
Current Ratio: 1.22 > 1.5 & < 3
Outstanding Shares: last quarter (364.8m) vs 12m ago 1.14% < -2%
Gross Margin: 75.50% > 18% (prev 73.96%; Δ 1.54% > 0.5%)
Asset Turnover: 75.90% > 50% (prev 72.00%; Δ 3.90% > 0%)
Interest Coverage Ratio: 2.55 > 6 (EBIT TTM 851.0m / Interest Expense TTM 334.0m)
Altman Z'' 2.87
A: 0.07 (Total Current Assets 7.61b - Total Current Liabilities 6.23b) / Total Assets 19.8b
B: 0.57 (Retained Earnings 11.3b / Total Assets 19.8b)
C: 0.04 (EBIT TTM 851.0m / Avg Total Assets 19.8b)
D: 0.24 (Book Value of Equity 3.81b / Total Liabilities 16.0b)
Altman-Z'' = 2.87 = A
Beneish M -3.10
DSRI: 0.94 (Receivables 1.52b/1.53b, Revenue 15.0b/14.3b)
GMI: 0.98 (GM 73.96% / 75.50%)
AQI: 0.94 (AQ_t 0.36 / AQ_t-1 0.39)
SGI: 1.05 (Revenue 15.0b / 14.3b)
TATA: -0.08 (NI 182.0m - CFO 1.77b) / TA 19.8b)
Beneish M = -3.10 (Cap -4..+1) = AA
What is the price of EL shares?

As of September 27, 2026, the stock is trading at USD 94.47 with a total of 2,762,991 shares traded. Over the past week, the price has changed by +1.11%, over one month by -9.59%, over three months by +16.31% and over the past year by +14.08%.

Current recommended Stop Loss: 87.90 (which is 7% or 2 ATR below the current price).

Is EL a buy, sell or hold?

Estee Lauder Companies has received a consensus analysts rating of 3.60. Therefore, it is recommended to hold EL.

  • StrongBuy: 6
  • Buy: 5
  • Hold: 13
  • Sell: 0
  • StrongSell: 1

What are the forecasts/targets for the EL price?
Analysts Target Price 107 13.3%
Estee Lauder Companies (EL) - Fundamental Data Overview as of 22 September 2026
Market Cap USD = 33.8b (33.8b USD * 1.0 USD.USD)
P/E Trailing = 186.86
P/E Forward = 28.169
P/S = 2.2462
P/B = 8.8815
P/EG = 2.1211
Revenue TTM = 15.0b USD
EBIT TTM = 851.0m USD
EBITDA TTM = 1.65b USD
Long Term Debt = 6.80b USD (from longTermDebt, last quarter)
Short Term Debt = 902.0m USD (from shortTermDebt, last quarter)
Debt = 11.2b USD (from shortLongTermDebtTotal, last quarter) + Leases 1.94b
Net Debt = 7.69b USD (calculated: Debt 11.2b - CCE 3.50b)
Enterprise Value = 41.5b USD (33.8b + Debt 11.2b - CCE 3.50b)
Interest Coverage Ratio = 2.55 (Ebit TTM 851.0m / Interest Expense TTM 334.0m)
EV/FCF = 31.53x (Enterprise Value 41.5b / FCF TTM 1.32b)
FCF Yield = 3.17% (FCF TTM 1.32b / Enterprise Value 41.5b)
FCF Margin = 8.74% (FCF TTM 1.32b / Revenue TTM 15.0b)
Net Margin = 1.21% (Net Income TTM 182.0m / Revenue TTM 15.0b)
Gross Margin = 75.50% ((Revenue TTM 15.0b - Cost of Revenue TTM 3.69b) / Revenue TTM)
Gross Margin QoQ = 80.90% (prev 71.04%)
Tobins Q-Ratio = 2.10 (Enterprise Value 41.5b / Total Assets 19.8b)
Interest Expense / Debt = 2.99% (Interest Expense 334.0m / Debt 11.2b)
Taxrate = 21.0% (US federal default 21%)
NOPAT = 672.3m (EBIT 851.0m * (1 - 21.00%))
Current Ratio = 1.22 (Total Current Assets 7.61b / Total Current Liabilities 6.23b)
Debt / Equity = 2.94 (Debt 11.2b / totalStockholderEquity, last quarter 3.81b)
Debt / EBITDA = 4.67 (Net Debt 7.69b / EBITDA 1.65b)
Debt / FCF = 5.84 (Net Debt 7.69b / FCF TTM 1.32b)
Total Stockholder Equity = 3.93b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.92% (Net Income 182.0m / Total Assets 19.8b)
RoE = 4.63% (Net Income TTM 182.0m / Total Stockholder Equity 3.93b)
RoCE = 7.93% (EBIT 851.0m / Capital Employed (Equity 3.93b + L.T.Debt 6.80b))
RoIC = 4.91% (NOPAT 672.3m / Invested Capital 13.7b)
WACC = 8.45% (E(33.8b)/V(45.0b) * Re(10.46%) + D(11.2b)/V(45.0b) * Rd(2.99%) * (1-Tc(0.21)))
Discount Rate = 10.46% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 89.08 | Cagr: 0.49%
[DCF] Terminal Value 77.66% ; FCFF base≈1.06b ; Y1≈1.21b ; Y5≈1.78b
[DCF] Fair Price = 75.70 (EV 26.4b - Net Debt 7.69b = Equity 18.7b / Shares 247.3m; r=8.45% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 3.34 | EPS CAGR: 0.72% | SUE: 0.48 | # QB: 0
Revenue Correlation: -66.07 | Revenue CAGR: -2.03% | SUE: 0.04 | # QB: 0
EPS current Quarter (2026-09-30): EPS=0.51 | Chg30d=+6.71% | Revisions=+39% | Analysts=21
EPS next Quarter (2026-12-31): EPS=1.21 | Chg30d=+2.87% | Revisions=+39% | Analysts=20
EPS current Year (2027-06-30): EPS=3.32 | Chg30d=+4.38% | Revisions=+61% | GrowthEPS=+32.4% | GrowthRev=+4.3%
EPS next Year (2028-06-30): EPS=3.91 | Chg30d=+2.23% | Revisions=+42% | GrowthEPS=+17.8% | GrowthRev=+4.3%
[Analyst] Revisions Ratio: +53% (up=55, down=16)